22.49
Vera Therapeutics Inc (VERA) 最新ニュース
FY2025 EPS Estimates for VERA Decreased by Cantor Fitzgerald - Defense World
Q2 EPS Forecast for Vera Therapeutics Reduced by Analyst - Defense World
Q2 EPS Estimates for Vera Therapeutics Boosted by Wedbush - Defense World
Hsbc Holdings PLC Takes $264,000 Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - The AM Reporter
Cantor Fitzgerald Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $100.00 - Defense World
Wedbush Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $26.00 - Defense World
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
What is Wedbush’s Estimate for VERA Q1 Earnings? - Defense World
Analysts Set Expectations for VERA Q2 Earnings - Defense World
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Vera Therapeutics (VERA) and Dexcom (DXCM) - The Globe and Mail
Analysts Issue Forecasts for VERA Q1 Earnings - Defense World
Decoding Vera Therapeutics Inc (VERA): A Strategic SWOT Insight - GuruFocus
Ratios Reveal: Breaking Down Vera Therapeutics Inc (VERA)’s Financial Health - DWinneX
Vera Therapeutics (VERA) Price Target Adjusted by Cantor Fitzgerald | VERA Stock News - GuruFocus
Vera Therapeutics Advances Atacicept in Key Trials - TipRanks
Vera Therapeutics shares fall as Q1 loss exceeds estimates By Investing.com - Investing.com Nigeria
Vera Therapeutics shares fall as Q1 loss exceeds estimates - Investing.com Australia
Medtronic gains after boosting full-year guidance By Investing.com - Investing.com India
Vera Therapeutics reports Q1 EPS (81c), consensus (78c) - TipRanks
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Vera Therapeutics (VERA) - The Globe and Mail
Vera Therapeutics' Q1 Net Loss Widens - marketscreener.com
Vera Therapeutics (VERA) Awaits Key Trial Results for Atacicept - GuruFocus
Vera Therapeutics (VERA) Awaits Key Trial Results for Atacicept | VERA Stock News - GuruFocus
Earnings Flash (VERA) Vera Therapeutics Posts Q1 Net Loss $0.81 a Share, vs. FactSet Est of $0.75 Loss - marketscreener.com
Vera Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results - The Manila Times
BRIEF-Vera Therapeutics Q1 EPS USD -0.81 Vs. IBES Estimate USD -0.74 - TradingView
Vera Therapeutics Nears Critical Phase 3 Readout with $589M War Chest for IgAN Drug Launch - Stock Titan
Vera Therapeutics (NASDAQ:VERA) Coverage Initiated by Analysts at HC Wainwright - Defense World
Vera Therapeutics (VERA) Gains Positive Outlook with Buy Rating - GuruFocus
Vera Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks
Vera Therapeutics (VERA) Receives New Buy Rating from HC Wainwri - GuruFocus
(VERA) On The My Stocks Page - news.stocktradersdaily.com
Invesco Ltd. Raises Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
A History of Outperforming Analyst Forecasts and Beating the Odds: Vera Therapeutics Inc (VERA) - Sete News
Vera Therapeutics Inc (VERA) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
Insider’s View: Deciphering Vera Therapeutics Inc (VERA)’s Financial Health Through Ratios - DWinneX
Vera Therapeutics Inc (VERA)’s stock performance: a year in review - uspostnews.com
Vera Therapeutics (VERA) Expected to Announce Earnings on Thursday - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Vera Therapeutics Inc (VERA) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Acquired by Wells Fargo & Company MN - Defense World
A stock that deserves closer examination: Vera Therapeutics Inc (VERA) - uspostnews.com
Traders Purchase Large Volume of Call Options on Vera Therapeutics (NASDAQ:VERA) - Defense World
Vera Therapeutics Inc (VERA): What Are The Positives? - Marketing Sentinel
When (VERA) Moves Investors should Listen - news.stocktradersdaily.com
Vera Therapeutics Inc (NASDAQ: VERA) Received An -47.05% Loss In 6 Months – Here’s What To Expect - Marketing Sentinel
Alliancebernstein L.P. Boosts Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics (VERA) Stock Sees After-Market Boost - Stocks Telegraph
After-Market Momentum Builds For ASP Isotopes (ASPI) Amid Secondary Listing News - Stocks Telegraph
Wellington Management Group LLP Trims Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by JPMorgan Chase & Co. - Defense World
Polycythemia Vera Market to Show Remarkable Growth Trends from - openPR.com
Polycythemia Vera Therapeutics Market Set to Witness - openPR.com
Kidney Disease-Focused Vera Therapeutics Concludes Enrollment In Pivotal Study, Targets 2026 Commercial Launch - Yahoo
Vanguard Group Inc. Acquires 369,387 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Corebridge Financial Inc. - Defense World
大文字化:
|
ボリューム (24 時間):